Kinetics of cytokine expression and regulation of host protection following infection with molecularly cloned venezuelan equine encephalitis virus

Virology

Volumn 233, Issue 2, 1997, Pages 302-312

  Grieder, Franziska B ^a   Davis, Belinda K ^a   Zhou, Xia Di ^a   Chen, Shen Jue ^a   Finkelman, Fred D ^b   Gause, William C ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ENCEPHALOMYELITIS; IMMUNE RESPONSE; IMMUNOREGULATION; INFECTION PREVENTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; VENEZUELAN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS; VIRUS REPLICATION; VIRUS VIRULENCE;

ALPHAVIRUS; ARBOVIRUS; EQUIDAE; VENEZUELAN EQUINE ENCEPHALITIS VIRUS;

EID: 0030874438     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8617     Document Type: Article

References (45)

1. Agapov, E. V., Razumov, I. A., Frolov, I. V., Kolykhalov, A. A., Netesov, S. V., and Loktev, V. B. (1994). Localization of four antigenic sites involved in Venezuelan equine encephalomyelitis virus protection. Arch. Virol. 139, 173-181.
2. Biron, C. A., and Gazzinelli, R. T. (1995). Effects of IL-12 on immune responses to microbial infections: A key mediator in regulating disease outcome. Curr. Opin. Immunol. 7, 485-496.
3. Burness, A. T., Pardoe, I., Faragner, S. G., Vrati, S., and Dalgaro, L. (1988). Genetic stability of Ross River virus during epidemic spread in nonimmune humans. Virology 167, 639-643.
4. Calisher, C. H. (1994). Medically important arboviruses of the United States and Canada. Clin. Microbiol. Rev. 7, 89-116.
5. Coutlier, J.-P., Van Broeck, J., and Wolf, S. F. (1995). Interleukin-12 gene expression after viral infection in the mouse. J. Virol. 69, 1955-1958.
6. Davis, N. L., Willis, L. V., Smith, J. F., and Johnston, R. E. (1989). In vitro synthesis of infectious Venezuelan equine encephalitis virus RNA from a cDNA clone: Analysis of a viable deletion mutant. Virology 171, 189-204.
7. 2 glycoprotein gene of Venezuelan equine encephalitis virus: Construction of single and multiple mutants in a full-length cDNA clone. Virology 18, 20-31.
8. Farrar, M. A., and Schreiber, R. D. (1993). The molecular cell biology of interferon-gamma and its receptor. Annu. Rev. Immunol. 11, 571-611.
9. Finkelman, F. D., Madden, K. B., Cheever, A. W., Katona, I. M., Morris, S. C., Gately, M. K., Hubbard, B. R., Gause, W. C., and Urban, J. F. (1994). Effects of interleukin-12 on immune responses and host protection in mice infected with intestinal nematode parasites. J. Exp. Med. 179, 1563-1572.
10. Fiorentino, D. F., Iotnik, A. Z., Vieira, P., Mosmann, T. R., Howard, M., Moore, K. W., and O'Garra, A. (1991). IL-10 acts on the antigen-presenting cells to inhibit cytokine production by Th1 cells. J. Immunol. 146, 3444-3453.
11. Gause, W. C., and Adamovicz, J. (1994). The use of the PCR to quantitate gene expression. PCR Methods Appl. 3(Suppl.): 123.
12. Gause, W. C., and Lu, P. (1996). Cellular sources and functions of cytokines during an immune response. In "Cytokine Regulation of Humoral Immunity," pp. 139-158. Wiley, New York.
13. Gresser, I. (1984). Role of interferon in resistance to viral infection in vivo. In "Interferon" (I. Vilcek and E. DeMaeyer, Eds.), pp. 221-247. Elsevier, Amsterdam.
14. Grieder, F. B., Davis, B. K., Zhou, X.-D., Finkelman, F. D., Gately, M. K., and Gause, W. C. (1996). IFN-α/β, but not IL-12, promotes a host protective type 1 murine immune response against Venezuelan equine encephalitis. [Abstract presented at the FASEB Summer Conference on Principles in Viral, Bacterial, Fungal, and Protozoan Pathogenesis, June 1996].
15. Grieder, F. B., and Nguyen, H. T. (1996). Virulent and attenuated mutant Venezuelan equine encephalitis virus show marked differences in replication in infected murine macrophages. Microb. Pathogen. 21, 85-95.
16. Grieder, F. B., Davis, N. L., Aronson, J. F., Charles, P. C., Sellon, D. C., Suzuki, K., and Johnston, R. E. (1995). Specific restrictions in the progression of Venezuelan equine encaphalitis virus-induced disease resulting from single amino acid changes in the glycoproteins. Virology 206, 994-1006.
17. Hunt, A. R., and Roehrig, J. T. (1995). Localization of a protective epitope on a Venezuelan equine encephalomyelitis (VEE) virus peptide that protects mice from both epizootic and enzootic VEE virus challenge and is immunogenic in horses. Vaccine 13, 281-288.
18. Johnson, B. J. B., Brubaker, J. R., Rohrig, J. T., and Trent, D. W. (1990). Variants of Venezuelan equine encephalitis virus that resist neutralization define a domain of the E2 glycoprotein. Virology 177, 676-683.
19. Lustig, S., Jackson, A., Hahn, C. S., Griffin, D. E., Strauss, E. G., and Strauss, J. H. (1988). Molecular basis of Sindbis virus neurovirulence in mice. J. Virol. 62, 2329-2336.
20. Morris, S. C., Madden, K. B., Adamovicz, J. J., Gause, W. C., Hubbard, B. R., and Finkelman, F. D. (1994). Effects of IL-12 on in vivo cytokine gene expression and Ig isotype election. J. Immunol. 152, 1047-1055.
21. Morbidity and Mortality Weekly Report (1995). "Update: Venezuelan Equine Encephalitis - Columbia, 1995," Vol. 44, pp. 775-777.
22. Moskophidis, D., Battegay, M., Bruendler, M.-A., Laine, E., Gresser, I., and Zinkernagel, R. M. (1994). Resistance of lymphocytic choriomeningitis virus to alpha/beta interferon and to gamma interferon. J. Virol. 68, 1951-1955.
23. Neta, R., Stiefel, S. M., Finkelman, F., Hermann, S., and Ali, N. (1994). IL-12 protects bone marrow from and sensitizes intestinal tract to ionizing radiation. J. Immunol. 153, 4230-4237.
24. Orange, J. S., Wolf, S. F., and Biron, C. A. (1994). Effects of IL-12 on the response and susceptibility to experimental viral infections. J. Immunol. 152, 1253-1264.
25. Orange, J. S., Salazar-Mather, T. S., Opal, S. M., Spencer, R. L., Miller, A. H., McEwen, B. S., and Biron, C. A. (1995a). Mechanism of interleukin 12-medicated toxicities during experimental viral infections: Role of tumor necrosis factor and glucocorticosteroids. J. Exp. Med. 181, 901-914.
26. Orange, J. S., Wang, B., Terhorst, C., and Biron, C. A. (1995b). Requirement for natural killer cell-produced interferon γ in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J. Exp. Med. 182, 1045-1056.
27. Orange, J. S., and Biron, C. A. (1996). An absolute and restricted requirement for IL-12 in natural killer cell IFN-γ production and antiviral defense. J. Immunol. 156, 1138-1142.
28. Ozmen, L., Aguet, M., Trinchieri, G., and Garotta, G. (1995). The in vivo antiviral activity of interleukin-12 is mediated by gamma interferon. J. Virol. 69, 8147-8150.
29. Rice, C. M., Bell, J. R., Hunkapiller, M. W., Strauss, E. G., and Strauss, J. H. (1982). Isolation and characterization of the hydrophobic COOH-terminal domain of the Sindbis virus glycoprotein. J. Mol. Biol. 154, 355-378.
30. Rice, C. M., and Strauss, J. H. (1982). Association of Sindbis virus glycoproteins and their precursors. J. Mol. Biol. 154, 325-348.
31. Roehrig, J. T., and Mathews, J. H. (1985). The neutralization site on the E2 glycoprotein of Venezuelan equine encephalomyelitis virus is composed of multiple conformationally-stable epitopes. Virology 142, 347-356.
32. Roehrig, J. T. (1986). The use of monoclonal antibodies in studies of the structural proteins of togviruses and flaviviruses. In "The Togaviridae and Flaviviridae" (S. Schlesinger and M. J. Schlesinger, Eds.), Plenum, New York.
33. Schijns, V. E. C., Haagmans, B. L., and Horzinek, M. C. (1995). IL-12 stimulates an antiviral type 1 cytokine response but lacks adjuvant activity in IFN-γ-receptor-deficient mice. J. Immunol. 155, 2525-2532.
34. Scott, P. (1993). IL-12: Initiation cytokine for cell-medicated immunity. Science 260, 496-497.
35. Sedegah, M., Finkelman, F., and Hoffman, S. L. (1994). Interleukin 12 induction of interferon gamma-dependent protection against malaris. Proc. Natl. Acad. Sci. USA 91, 10700-10702.
36. Svetic, A., Finkelman, F. D., Jan, Y. C., Diffenbach, C. W., Scott, D. E., McCarthy, K. F., Stainberg, A. D., and Gause, W. C. (1991). Cytokine gene expression after in vivo primary immunization with goat antibody to mouse IgD antibody. J. Immunol. 147, 2391-2399.
37. + T cells. Int. Immunol. 5, 877-883.
38. Sher, A., and Coffman, R. L. (1992). Regulation of immunity to parasites and T cell-derived cytokines. Annu. Rev. Immunol. 10, 38-396.
39. Trinchieri, G. (1994). Interleukine 12: A cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 84, 4008-4027.
40. Tripp, C. S., Gately, M. K., Hakimi, J., Ling, P., and Unanue, E. R. (1994). Neutralization of IL-12 decreases resistance to Listeria in SCID and C.B-17 mice: Reversal by IFN-gamma. J. Immunol. 152, 1883-1887.
41. Tucker, P. C., and Griffin, D. E. (1991). Mechanism of altered Sindbis virus neurovirulence associated with a single-amino-acid change in E2 glycoprotein. J. Virol. 65, 1551-1557.
42. Urban, J. F., Fayer, R., Chen, S.-J., Gause, W. C., Gately, M. K., and Finkelman, F. D. (1996). IL-12 protects immunocompetent and immunodeficient neonatal mice against infection with cryptosporidium parvum. J. Immunol. 156, 263-268.
43. Wesselingh, S. L., Levine, B., Fox, R. J., Choi, S., and Griffin, D. E. (1994). Intracerebral cytokine mRNA expression during fatal and nonfatal alphavirus encephalitis suggests a predominant type 2 T cell response. J. Immunol. 152, 1289-1297.
44. Williamson, E., Garside, P., Bradley, J. A., and Mowat, A. M. (1996). IL-12 is a central mediator of acute graft-versus-host disease in mice. J. Immunol. 157, 689-699.
45. Whartenby, K. A., Abboud, C. N., Marrogi, A. J., Ramesh, R., and Freeman, S. M. (1995). The biology of cancer gene therapy. Lab. Invest. 72, 131-145.